ICON plc to Present at the Barclays Global Healthcare Conference & the KeyBanc Capital Markets' Life Sciences & MedTech Inves...
March 09 2021 - 9:00AM
Business Wire
ICON plc, (NASDAQ: ICLR) a global provider of outsourced drug
and device development and commercialisation services to
pharmaceutical, biotechnology, medical device and government and
public health organisations, today announced that Mr. Brendan
Brennan, CFO of ICON plc, will present at:
- The Barclays Global Healthcare Conference on Wednesday, March
10, 2021. The presentation will be webcast live from 08.00am ET;
and
- the KeyBanc Capital Markets' Life Sciences & MedTech
Investor Forum on Wednesday, March 24, 2021 at 11.30am ET.
Any changes to these events and links to the live webcasts
(where available) will be posted on the Investor section of our
website under “Events”.
About ICON plc
ICON plc is a global provider of outsourced drug and device
development and commercialisation services to pharmaceutical,
biotechnology, medical device and government and public health
organisations. The company specialises in the strategic
development, management and analysis of programs that support
clinical development - from compound selection to Phase I-IV
clinical studies. With headquarters in Dublin, Ireland, ICON
employed approximately 15,730 employees in 93 locations in 41
countries as at December 31, 2020. For further information about
ICON, visit: www.iconplc.com.
This press release and the related presentations in connection
with this press release contain forward-looking statements. These
statements are based on management's current expectations and
information currently available, including current economic and
industry conditions. These statements are not guarantees of future
performance or actual results, and actual results, developments and
business decisions may differ from those stated in this press
release. The forward-looking statements are subject to future
events, risks, uncertainties and other factors that could cause
actual results to differ materially from those projected in the
statements, including, but not limited to, the ability to enter
into new contracts, maintain client relationships, manage the
opening of new offices and offering of new services, the
consummation and integration of new business mergers and
acquisitions, the impact of COVID-19 on our business, as well as
other economic and global market conditions and other risks and
uncertainties detailed from time to time in SEC reports filed by
ICON, all of which are difficult to predict and some of which are
beyond our control. For these reasons, you should not place undue
reliance on these forward-looking statements when making investment
decisions. The word "expected" and variations of such words and
similar expressions are intended to identify forward-looking
statements. Forward-looking statements are only as of the date they
are made and we do not undertake any obligation to update publicly
any forward-looking statement, either as a result of new
information, future events or otherwise. More information about the
risks and uncertainties relating to these forward-looking
statements may be found in SEC reports filed by ICON, including its
Form 20-F, F-1, S-8 and F-3, which are available on the SEC's
website at http://www.sec.gov.
In addition, as announced, ICON and PRA Health Services (“PRA”)
have entered into a definitive merger agreement. This communication
does not constitute an offer to sell or buy or the solicitation of
any offer to buy or sell any securities, nor shall there be any
sale of securities in a jurisdiction in which such offer,
solicitation, or sale would be unlawful prior to registration or
qualification under the securities law of any such jurisdiction. No
offering of securities shall be made except by means of a
prospectus meeting regulatory requirements of Section 10 of the
Securities Act of 1933. In connection with the proposed
transaction, ICON expects to file a registration statement on Form
F-4 with the SEC containing a preliminary prospectus of ICON that
also constitutes a preliminary proxy statement of each of ICON and
PRA. ICON and PRA will file other documents regarding the proposed
transaction with the SEC.
Before making any voting or investment decisions, investors and
security holders of ICON and PRA stock are encouraged to carefully
read the entire registration statement and proxy statement
prospectus when filed and made available on each of our websites
and at sec.gov.
Source: ICON plc
ICON/ICLR-G
View source
version on businesswire.com: https://www.businesswire.com/news/home/20210309005686/en/
Investor Relations +1888 381 7923 Jonathan Curtain Vice
President Corporate Finance and Investor Relations +353 1 291
2000
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Sep 2024 to Oct 2024
ICON (NASDAQ:ICLR)
Historical Stock Chart
From Oct 2023 to Oct 2024